⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2644861 | 0.80 | — | — | |
| SCHEMBL2644361 | 0.76 | — | — | |
| SCHEMBL2806109 | 0.76 | — | — | |
| SCHEMBL2806106 | 0.76 | — | — | |
| SCHEMBL9074259 | 0.74 | ALDH1A1 (0.34) | — | |
| SCHEMBL3024906 | 0.73 | — | — | |
| SCHEMBL4722131 | 0.73 | — | — | |
| SCHEMBL14481547 | 0.71 | — | — | |
| SCHEMBL10859790 | 0.71 | — | — | |
| SCHEMBL1902706 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969716-B2 | 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression | MERCK SHARP & DOHME LTD. | 2005-11-29 | — | — | US | disclosed |
| US-20040192692-A1 | 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression | MERCK SHARP & DOHME, LTD. (GB) | 2004-09-30 | — | — | US | disclosed |
| EP-0968222-B1 | NOVEL ERYTHROMYCIN DERIVATIVES, METHOD OF PREPARATION AND APPLICATION AS MEDICINES | AVENTIS PHARMA SA (FR) | 2002-06-12 | — | — | EP | disclosed |
| EP-0968222-A1 | NOVEL ERYTHROMYCIN DERIVATIVES, METHOD OF PREPARATION AND APPLICATION AS MEDICINES | HOECHST MARION ROUSSEL (FR) | 2000-01-05 | — | — | EP | disclosed |
| WO-1998038199-A1 | NOVEL ERYTHROMYCIN DERIVATIVES, METHOD OF PREPARATION AND APPLICATION AS MEDICINES | HOECHST MARION ROUSSEL (FR) | 1998-09-03 | — | — | WO | disclosed |
| US-5770579-A | Erythromycin compounds | ROUSSEL UCLAF (FR) | 1998-06-23 | — | — | US | disclosed |
| US-5561118-A | ANTIBIOTICS | ROUSSEL UCLAF (FR) | 1996-10-01 | — | — | US | disclosed |
| EP-0487411-B1 | Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments | ROUSSEL UCLAF (FR) | 1996-01-31 | — | — | EP | disclosed |
| US-5444051-A | BACTERICIDES | ROUSSEL UCLAF (FR) | 1995-08-22 | — | — | US | disclosed |
| EP-0487411-A1 | Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments | ROUSSEL UCLAF (FR) | 1992-05-27 | — | — | EP | disclosed |
| EP-0033255-B1 | OXIMES DERIVED FROM ERYTHROMYCIN A, THEIR PREPARATION, THEIR APPLICATION IN PHARMACEUTICALS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1984-08-29 | — | — | EP | disclosed |
| US-4349545-A | Novel erythromycin a derivatives | ROUSSEL UCLAF (FR) | 1982-09-14 | — | — | US | disclosed |
| EP-0033255-A1 | Oximes derived from erythromycin A, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1981-08-05 | — | — | EP | disclosed |